Organigram fixes Sanity Group earnout, moves to unified global operating structure

Organigram Global Inc. announced on August 20, 2026 that it is accelerating integration of Sanity Group GmbH, aligning leadership and operations under what it called a unified global structure spanning Canada, Germany, Switzerland, Poland, Czechia, the United Kingdom and Australia.

The company said the share purchase agreement governing the Sanity acquisition had required that Sanity operate independently for a 12-month period tied to an earnout.¹ Organigram has now amended that agreement so that a fixed earnout replaces the original performance-based structure, though the earnout still becomes payable after that period ends.¹

Under the new terms, the parties agreed to fix the earnout at 85% of the maximum value contemplated in the original acquisition agreement.¹ The earnout consideration will consist of €20 million in cash, with the remaining consideration, net of Organigram's pre-acquisition interests and certain other deductions, of approximately €76 million payable in Organigram shares.¹ The number of shares to be issued will be based on the 20-day volume-weighted average trading price on the TSX three days before payment, subject to a floor of C$3.00 and a cap of C$4.00 per share.¹ The earnout becomes payable as of April 1, 2027, with actual payment due no later than May 1, 2027.¹

The company also said the amended earnout qualifies as a related party transaction under Multilateral Instrument 61-101 but is exempt from formal valuation and minority shareholder approval requirements because neither the fair market value nor the consideration involved exceeds 25% of Organigram's market capitalization.¹

As part of the restructuring, Finn Age Hänsel was appointed President, Rest of World & Chief Strategy Officer, and Adrian Frenzel was named Global Chief Operating Officer, while Tim Emberg continues as President, Canada.¹ The release noted Sanity contributed approximately CAD$40 million to Organigram's consolidated net revenue in its most recent quarter, over 35% of total net revenue, and was accretive to Adjusted EBITDA.¹